Atai Life Sciences Other Long-Term Assets 2020-2024 | ATAI
Atai Life Sciences other long-term assets from 2020 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
| Atai Life Sciences Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2023 | $3 |
| 2022 | $3 |
| 2021 | $7 |
| 2020 | $0 |
| 2019 | $ |
| Atai Life Sciences Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-06-30 | $2 |
| 2024-03-31 | $3 |
| 2023-12-31 | $3 |
| 2023-09-30 | $3 |
| 2023-06-30 | $3 |
| 2023-03-31 | $3 |
| 2022-12-31 | $3 |
| 2022-09-30 | $9 |
| 2022-06-30 | $8 |
| 2022-03-31 | $8 |
| 2021-12-31 | $7 |
| 2021-09-30 | $1 |
| 2021-06-30 | $1 |
| 2021-03-31 | $1 |
| 2020-12-31 | $0 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.208B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $21.379B | 12.93 |
| Quest Diagnostics (DGX) | United States | $17.308B | 17.75 |
| DaVita (DVA) | United States | $13.689B | 16.84 |
| Encompass Health (EHC) | United States | $9.303B | 22.88 |
| Chemed (CHE) | United States | $8.694B | 26.73 |
| Elanco Animal Health (ELAN) | United States | $7.242B | 16.28 |
| Option Care Health (OPCH) | United States | $5.321B | 26.14 |
| RadNet (RDNT) | United States | $4.963B | 117.74 |
| Amedisys (AMED) | United States | $3.181B | 22.75 |
| Astrana Health (ASTH) | United States | $2.805B | 39.69 |
| LifeStance Health (LFST) | United States | $2.579B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.399B | 29.12 |
| U.S Physical Therapy (USPH) | United States | $1.274B | 34.50 |
| Pennant (PNTG) | United States | $1.057B | 50.71 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.022B | 0.00 |
| Daxor (DXR) | United States | $0.045B | 0.00 |
| ATI Physical Therapy (ATIP) | United States | $0.025B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.019B | 0.00 |
| Psychemedics (PMD) | United States | $0.014B | 0.00 |
| Ontrak (OTRK) | United States | $0.010B | 0.00 |
| Novo Integrated Sciences (NVOS) | United States | $0.006B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.002B | 0.00 |